Measures for pharmaceutical Representatives filing -Trial

On September 30, the National medical product administration issued the administrative measures for the record keeping of medical representatives (for Trial Implementation), which will come into effect on December 1, 2020. The filing platform is constructed and maintained by China Pharmaceutical Association. The marketing authorization holder-MAH shall be responsible for the filing and management of the pharmaceutical representative; if the MAH is an overseas enterprise, the designated domestic agent shall perform the corresponding responsibility The MAH shall sign a labor contract or power of attorney with the medical representative, and record the information of the pharmaceutical representative on the recordRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is CNY 5000 Best! Paolo yue Email: Cell: 008613501397114

Existing Users Log In
New User Registration
*Required field